Zobrazeno 1 - 10
of 805
pro vyhledávání: '"Mohamed A. Yassin"'
Autor:
Syed Muzzamil Hussain Shah, Sani I. Abba, Mohamed A. Yassin, Dahiru U. Lawal, Farouq Aliyu, Ebrahim Hamid Hussein Al-Qadami, Haris U. Qureshi, Isam H. Aljundi, Hamza A. Asmaly, Saad Sh. Sammen, Miklas Scholz
Publikováno v:
Environmental Sciences Europe, Vol 36, Iss 1, Pp 1-14 (2024)
Abstract The agricultural sector faces challenges in managing water resources efficiently, particularly in arid regions dealing with water scarcity. To overcome water stress, treated wastewater (TWW) is increasingly utilized for irrigation purpose to
Externí odkaz:
https://doaj.org/article/c4154040166f4181891a71b7334cee48
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 96-100 (2024)
Introduction: Chronic myeloid leukemia (CML) is characterized by the presence of the BCR::ABL1 fusion gene, and the advent of tyrosine kinase inhibitors (TKIs) has revolutionized its therapeutic landscape. Asciminib, a STAMP inhibitor, emerges as a p
Externí odkaz:
https://doaj.org/article/6fc7a1e3a31844ef9c8f1576aebc59a0
Autor:
Mohammad S. Afana, Mohammad Abu-Tineh, Awni Alshurafa, Khalid Ahmed, Mohammed Abdulgayoom, Mohamed A. Yassin
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 91-95 (2024)
Introduction: Polycythemia vera (PV) is one of the myeloproliferative neoplasms (MPN) diagnosed by World Health Organization (WHO) criteria 2016, which requires the presence of 3 major criteria: high hemoglobin/hematocrit, bone marrow findings, and J
Externí odkaz:
https://doaj.org/article/ce0de06cb3634723811c73a281c827b6
Autor:
Yasamin Abdu, Khalid Ahmed, Mariam Abdou, Rayan Elhussein, Sayda Sirelkhatim, Iheb Bougmiza, Mohamed A. Yassin, Nagah A. Selim
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundHematological cancers impose a complex burden on individuals, affecting their physical health and mental and emotional well-being. This study evaluated the health-related Quality of Life (HRQOL) and its determinants among adults with hemato
Externí odkaz:
https://doaj.org/article/f86b5d7b8b0a47d0b4f2396d47e46992
Publikováno v:
Clinical Case Reports, Vol 12, Iss 5, Pp n/a-n/a (2024)
Key Clinical Message This case report and literature review examine the use of a relatively novel agent in a transfusion‐dependent beta‐thalassemia patient with extramedullary hematopoiesis (EMH). It examines the benefits and risks associated wit
Externí odkaz:
https://doaj.org/article/d12d3311d6084e73b5166153b81bcc3e
Publikováno v:
Clinical Case Reports, Vol 12, Iss 5, Pp n/a-n/a (2024)
Key Clinical Message This report documents the treatment of a 41‐year‐old male with sickle cell disease (SCD) and repeated stuttering priapism using crizanlizumab, which alleviated the priapism but induced a significant vaso‐occlusive crisis du
Externí odkaz:
https://doaj.org/article/e0b4af9978ef4f7383392d490e7ce4f1
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1073-1079 (2023)
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm in which granulocytic cells are the main proliferative component. At diagnosis, more than 90% of CML cases have the characteristic Philadelphia chromosome, containing the BCR::ABL1 fusio
Externí odkaz:
https://doaj.org/article/a5bebea6a8f14a6d86fc287ad9278bde
Autor:
Elrazi A. Ali, Anas Al-Sadi, Qusai Al-maharmeh, Eihab A. Subahi, Amulya Bellamkonda, Madhumati Kalavar, Kalpana Panigrahi, Awni Alshurafa, Mohamed A. Yassin
Publikováno v:
Frontiers in Medicine, Vol 10 (2024)
IntroductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus causing the coronavirus disease of 2019. The disease has caused millions of deaths since the first pandemic at the end of 2019. Immunocompromised individuals are mo
Externí odkaz:
https://doaj.org/article/afb890a8d1f6448a9d6f9a6d17ee8736
Autor:
Fateen Ata, Maria Benkhadra, Rola Ghasoub, Liam J. Fernyhough, Nabil E. Omar, Abdulqadir J. Nashwan, Mahmood B. Aldapt, Kamran Mushtaq, Nancy A. Kassem, Mohamed A. Yassin
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Tyrosine Kinase Inhibitors (TKIs) is revolutionizing the management of pediatric Chronic Myeloid Leukemia (CML), offering alternatives to Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT). We conducted a comprehensive review of 16 Randomized
Externí odkaz:
https://doaj.org/article/e62c82df25e14e98bf14c3a857c6f348
Autor:
Mohamed A. Yassin, Mona Al-Rasheed, Murtadha Al-Khaboori, Mahmoud Marashi, Hani Osman, Yasser Wali, Salam Al Kindi, Faisal Alsayegh, Drew Provan
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionThrombopoietin-receptor agonist (TPO-RAs) currently represent the state of art for treating immune thrombocytopenia. Their different molecular structures contribute to the difference in their pharmacodynamics and pharmacokinetics. This na
Externí odkaz:
https://doaj.org/article/4f6a087b656b418f86cf0903c7502c43